Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. (300452.SZ)
CNY 12.75
(0.24%)
CNY 12.75
(0.24%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 839.25 Million | 704.52 Million | 616.7 Million | 531.19 Million | 464.06 Million | 428.55 Million |
| Cost of Revenue | 573.28 Million | 494.75 Million | 438.52 Million | 366.75 Million | 294.52 Million | 283.2 Million |
| Gross Profit | 265.97 Million | 209.76 Million | 178.18 Million | 164.43 Million | 169.54 Million | 145.35 Million |
| Operating Expenses | 79.88 Million | 80.64 Million | 79.03 Million | 57.96 Million | 70.58 Million | 62.61 Million |
| Selling, General and Administrative Expenses | 34.44 Million | 28.55 Million | 29.77 Million | 25.99 Million | 42.4 Million | 38.42 Million |
| Research and Development Expenses | 41.95 Million | 34.42 Million | 26.8 Million | 18.11 Million | 16.19 Million | 14.19 Million |
| Other Expenses | -22.1 Million | 125.87 Thousand | -3.02 Million | -1.79 Million | -404.75 Thousand | 2.02 Million |
| Cost and Expenses | 653.81 Million | 575.4 Million | 517.56 Million | 424.72 Million | 365.11 Million | 345.81 Million |
| Operating Income | 185.44 Million | 136.27 Million | 99.7 Million | 108.96 Million | 103.69 Million | 88.36 Million |
| Interest Expense | 4.29 Million | 1.21 Million | 1.2 Million | 728.38 Thousand | 84.32 Thousand | 500.26 Thousand |
| Income Tax Expense | 21.19 Million | 5.47 Million | 11.14 Million | 13.64 Million | 13.06 Million | 13.19 Million |
| Earnings before Tax | 185.81 Million | 136.4 Million | 96.68 Million | 107.17 Million | 103.24 Million | 90.39 Million |
| Net Income | 161.53 Million | 130.7 Million | 89.25 Million | 93.94 Million | 84.37 Million | 70.1 Million |
| Earnings Per Share Basic | 0.69 | 0.56 | 0.38 | 0.41 | 0.36 | 0.30 |
| Earnings Per Share Diluted | 0.67 | 0.56 | 0.38 | 0.41 | 0.36 | 0.30 |
| Weighted Average Shares Outstanding | 234.1 Million | 233.4 Million | 234.6 Million | 230.42 Million | 233.36 Million | 235.24 Million |
| Weighted Average Shares Outstanding (Diluted) | 241.09 Million | 233.4 Million | 234.6 Million | 230.42 Million | 233.36 Million | 236.96 Million |
| Gross Margin | 0.32 | 0.30 | 0.29 | 0.31 | 0.37 | 0.34 |
| EBIT Margin | 0.27 | 0.25 | 0.22 | 0.26 | 0.27 | 0.23 |
| Profit Margin | 0.19 | 0.19 | 0.14 | 0.18 | 0.18 | 0.16 |
| EBITDA | 228.9 Million | 173.68 Million | 132.95 Million | 139.65 Million | 123.23 Million | 98.85 Million |
| Earnings Before Tax Margin | 0.22 | 0.19 | 0.16 | 0.21 | 0.22 | 0.21 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 194.42 Million | 212.23 Million | 237.68 Million | 839.25 Million | 198.9 Million | 187.41 Million |
| Cost of Revenue | 137.54 Million | 140.96 Million | 158.43 Million | 573.28 Million | 134.67 Million | 130.09 Million |
| Gross Profit | 56.88 Million | 71.27 Million | 79.25 Million | 265.97 Million | 64.22 Million | 57.31 Million |
| Operating Expenses | 21.25 Million | 22.4 Million | 25.62 Million | 95.49 Million | 25.73 Million | 21.95 Million |
| Selling, General and Administrative Expenses | 29.63 Million | 10.08 Million | 14.09 Million | - | -5.86 Million | 23.75 Million |
| Research and Development Expenses | 6.8 Million | 10.16 Million | 11.78 Million | - | 11.27 Million | 8.44 Million |
| Other Expenses | -15.18 Million | 150.77 Thousand | 74.82 Thousand | 375.15 Thousand | -80.79 Thousand | 200.76 Thousand |
| Cost and Expenses | 158.79 Million | 163.36 Million | 184.05 Million | 668.78 Million | 160.41 Million | 152.05 Million |
| Operating Income | 30.51 Million | 51.84 Million | 57.17 Million | 185.44 Million | 43.76 Million | 39.16 Million |
| Interest Expense | 3.43 Million | 3.3 Million | 3.29 Million | 4.29 Million | 1.83 Million | 1.62 Million |
| Income Tax Expense | 3.47 Million | 6.21 Million | 6.72 Million | 21.19 Million | 4.74 Million | 4.56 Million |
| Earnings before Tax | 30.62 Million | 51.99 Million | 57.24 Million | 185.81 Million | 43.68 Million | 39.37 Million |
| Net Income | 26.89 Million | 45.71 Million | 49.81 Million | 161.53 Million | 38 Million | 35.2 Million |
| Earnings Per Share Basic | 0.12 | 0.20 | 0.21 | - | 0.16 | 0.15 |
| Earnings Per Share Diluted | 0.12 | 0.19 | 0.21 | - | 0.14 | 0.15 |
| Weighted Average Shares Outstanding | 232.62 Million | 232.62 Million | 237.21 Million | 234.1 Million | 237.2 Million | 234.46 Million |
| Weighted Average Shares Outstanding (Diluted) | 232.62 Million | 243.8 Million | 237.21 Million | 241.09 Million | 265.16 Million | 234.46 Million |
| Gross Margin | 0.29 | 0.34 | 0.33 | 0.32 | 0.32 | 0.31 |
| EBIT Margin | 0.18 | 0.24 | 0.24 | - | 0.23 | 0.20 |
| Profit Margin | 0.14 | 0.22 | 0.21 | 0.19 | 0.19 | 0.19 |
| EBITDA | 34.05 Million | 51.76 Million | 58 Million | - | 45.2 Million | 37.12 Million |
| Earnings Before Tax Margin | 0.16 | 0.24 | 0.24 | 0.22 | 0.22 | 0.21 |
ISLAX
SEAC
2852
GNYPF
MBHCF
RSPI